Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

1.

Immune function and muscle adaptations to resistance exercise in older adults: study protocol for a randomized controlled trial of a nutritional supplement.

Dennis RA, Ponnappan U, Kodell RL, Garner KK, Parkes CM, Bopp MM, Padala KP, Peterson CA, Padala PR, Sullivan DH.

Trials. 2015 Mar 27;16(1):121. [Epub ahead of print]

2.

Practical advice on calculating confidence intervals for radioprotection effects and reducing animal numbers in radiation countermeasure experiments.

Landes RD, Lensing SY, Kodell RL, Hauer-Jensen M.

Radiat Res. 2013 Dec;180(6):567-74. doi: 10.1667/RR13429.1. Epub 2013 Oct 28.

3.

A diversity index for model space selection in the estimation of benchmark and infectious doses via model averaging.

Kim SB, Kodell RL, Moon H.

Risk Anal. 2014 Mar;34(3):453-64. doi: 10.1111/risa.12104. Epub 2013 Aug 26.

PMID:
23980524
4.

Subpopulation-specific confidence designation for more informative biomedical classification.

Zhang C, Kodell RL.

Artif Intell Med. 2013 Jul;58(3):155-63. doi: 10.1016/j.artmed.2013.04.008. Epub 2013 Jun 2.

5.

Multinomial logistic regression ensembles.

Lee K, Ahn H, Moon H, Kodell RL, Chen JJ.

J Biopharm Stat. 2013 May;23(3):681-94. doi: 10.1080/10543406.2012.756500.

PMID:
23611203
6.

Quantitative benefit-risk analysis for evaluating drug therapies.

Kodell RL, Chen JJ.

J Biopharm Stat. 2013;23(1):231-8. doi: 10.1080/10543406.2013.735785.

PMID:
23331233
7.

Estimating misclassification error: a closer look at cross-validation based methods.

Ounpraseuth S, Lensing SY, Spencer HJ, Kodell RL.

BMC Res Notes. 2012 Nov 28;5:656. doi: 10.1186/1756-0500-5-656.

8.

Assessment of performance of survival prediction models for cancer prognosis.

Chen HC, Kodell RL, Cheng KF, Chen JJ.

BMC Med Res Methodol. 2012 Jul 23;12:102. doi: 10.1186/1471-2288-12-102.

9.

A selective voting convex-hull ensemble procedure for personalized medicine.

Nagarajan R, Kodell RL.

AMIA Jt Summits Transl Sci Proc. 2012;2012:87-94. Epub 2012 Mar 19.

10.

Model uncertainty and model averaging in the estimation of infectious doses for microbial pathogens.

Moon H, Kim SB, Chen JJ, George NI, Kodell RL.

Risk Anal. 2013 Feb;33(2):220-31. doi: 10.1111/j.1539-6924.2012.01853.x. Epub 2012 Jun 9.

PMID:
22681783
11.

Statistical analysis of survival data from radiation countermeasure experiments.

Landes RD, Lensing SY, Kodell RL, Hauer-Jensen M.

Radiat Res. 2012 May;177(5):546-54. Epub 2012 Mar 8.

12.

Selective voting in convex-hull ensembles improves classification accuracy.

Kodell RL, Zhang C, Siegel ER, Nagarajan R.

Artif Intell Med. 2012 Mar;54(3):171-9. doi: 10.1016/j.artmed.2011.10.003. Epub 2011 Nov 6.

13.

A review of mammalian carcinogenicity study design and potential effects of alternate test procedures on the safety evaluation of food ingredients.

Hayes AW, Dayan AD, Hall WC, Kodell RL, Williams GM, Waddell WD, Slesinski RS, Kruger CL.

Regul Toxicol Pharmacol. 2011 Jun;60(1 Suppl):S1-34. doi: 10.1016/j.yrtph.2010.10.002. Epub 2010 Nov 19.

PMID:
21094668
14.

Determination of sample sizes for demonstrating efficacy of radiation countermeasures.

Kodell RL, Lensing SY, Landes RD, Kumar KS, Hauer-Jensen M.

Biometrics. 2010 Mar;66(1):239-48. doi: 10.1111/j.1541-0420.2009.01236.x. Epub 2009 May 7.

15.

A model-free ensemble method for class prediction with application to biomedical decision making.

Kodell RL, Pearce BA, Baek S, Moon H, Ahn H, Young JF, Chen JJ.

Artif Intell Med. 2009 Jul;46(3):267-76. doi: 10.1016/j.artmed.2008.11.001. Epub 2008 Dec 9.

PMID:
19081231
16.

Estimation of lag time between onset of and death from an occult tumor.

Ahn H, Moon H, Kodell RL.

J Biopharm Stat. 2008;18(5):901-14. doi: 10.1080/10543400802287453.

PMID:
18781524
17.

Identifying high-dimensional biomarkers for personalized medicine via variable importance ranking.

Baek S, Moon H, Ahn H, Kodell RL, Lin CJ, Chen JJ.

J Biopharm Stat. 2008;18(5):853-68. doi: 10.1080/10543400802278023.

PMID:
18781521
18.

Analysis of in vivo mutation data can inform cancer risk assessment.

Moore MM, Heflich RH, Haber LT, Allen BC, Shipp AM, Kodell RL.

Regul Toxicol Pharmacol. 2008 Jul;51(2):151-61. doi: 10.1016/j.yrtph.2008.01.015. Epub 2008 Feb 1.

PMID:
18321622
19.

Modeling and assaying dioxin-like biological effects for both dioxin-like and certain non-dioxin-like compounds.

Wilkes JG, Hass BS, Buzatu DA, Pence LM, Archer JC, Beger RD, Schnackenberg LK, Halbert MK, Jennings L, Kodell RL.

Toxicol Sci. 2008 Mar;102(1):187-95. Epub 2007 Dec 7.

20.

Ensemble methods for classification of patients for personalized medicine with high-dimensional data.

Moon H, Ahn H, Kodell RL, Baek S, Lin CJ, Chen JJ.

Artif Intell Med. 2007 Nov;41(3):197-207. Epub 2007 Aug 23.

PMID:
17719213
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk